Skip to content

FP7H2020HORIZON

Glaxosmithkline Research & Development Limited

Country
GBUnited Kingdom
Defence projects
0
Projects, all programmes
87
As coordinator
7
EU contribution (CORDIS)
EUR 2,550,777
Active
2008 to 2026

Projects

87 projects, newest first

Projects, newest first
ProjectProgrammeYearRoleEU contribution
EFOEUPATIEnsuring the future of EUPATI beyond 2020H20202018ParticipantEUR 0
PARADIGMPatients Active in Research and Dialogues for an Improved Generation of Medicines: Advancing meaningful patient engagement in the life cycle of medicines for better health outcomes.H20202018ParticipantEUR 0
c4cconect4children (COllaborative Network for European Clinical Trials For Children)H20202018ParticipantEUR 0
iConsensusIntegrated control and sensing platform for biopharmaceutical cultivation process high-throughput development and productionH20202018ParticipantEUR 0
PhotoBioCatLight-driven sustainable biocatalysis training networkH20202018PartnerEUR 0
GetReal InitiativeThe GetReal InitiativeH20202018ParticipantEUR 0
DO-ITBig Data for Better Outcomes, Policy Innovation and Healthcare System Transformation - Sofia ref.: 116055H20202017ParticipantEUR 0
ES-CatDirected Protein Evolution for Synthetic Biology and BiocatalysisH20202017PartnerEUR 0
TransQSTTranslational quantitative systems toxicology to improve the understanding of the safety of medicines - Sofia: 116030H20202017ParticipantEUR 0
InSCOPEINternational Smart Collaborative Open-access hybrid Printed Electronics pilot lineH20202017ParticipantEUR 323,750
IB4SD-TRISTANImaging Biomarkers (IBs) for Safer Drugs: Validation of Translational Imaging Methods in Drug Safety Assessment - Sofia ref.: 116106H20202017ParticipantEUR 0
RTCureRheuma Tolerance for CureH20202017ParticipantEUR 0
TASPPITargeted small-molecule Stabilisation of Protein-Protein InteractionsH20202016PartnerEUR 0
GrapheneCore1Graphene-based disruptive technologiesH20202016ParticipantEUR 77,281
ND4IDNew Diagnostics for Infectious Diseases: “ND4ID”H20202016PartnerEUR 0
FRAGNETFRAGments training NETworkH20202016PartnerEUR 0
EPIMACThe next generation epigenetic medicine for inflammationH20202015ParticipantEUR 273,288
TCCMTheoretical Chemistry and Computational ModellingH20202015PartnerEUR 0
ProPATRobust and affordable process control technologies for improving standards and optimising industrial operationsH20202015ParticipantEUR 223,750
APPROACHApplied Public-Private Research enabling OsteoArthritis Clinical HeadwayFP72015CoordinatorNot stated

The country is the one the source records for the organisation’s registration (its PIC), and each profile says what it rests on. Where the record contradicts itself (the address in one country, the site name and the VAT number in another) we follow the two that agree: the Spanish research council CSIC is shown under Spain although its address is recorded in Italy. A body with sites in several countries is shown under the first of them in alphabetical order, and its profile lists the others. Beyond that we do not guess.

Where this comes from

EU contribution is the amount CORDIS's open data pays to the participant. For a participant with linked third parties it may include their share (the CORDIS page prints the net); an amount the data does not hold is left out, not counted as zero. EDF factsheets state none per participant, so EDF projects count as projects but add nothing to the amounts.

Organisation-level facts only: a name, a country, a role, an amount, a year. A participant is recognised by its PIC where the source gives one, otherwise by name; the page says which. How the data is built.

Names are as CORDIS and the EDF project factsheets publish them. We do not list an organisation whose name looks like a natural person’s. If this entry is you, or a business named after you, and you want it removed, write to the contact in the imprint; the privacy notice (sections 7 and 9) says how a request is handled.